Delivery Order SPE2DB22D2103-SPE2DB24FR8QU
- Not listed
- This federal contract award, valued at $1,649.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 contract running through November 2026. This IDC enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award, valued at $12,420.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to support...
- This federal contract award is a delivery order valued at $63,462.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Otezla 30 mg tablets, a medication used to treat various conditions. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $12,808.78, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,011.71, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,026.47, is a delivery order for the provision of Otezla 30 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,081.51 firm fixed-price delivery order is for the supply of OTEZLA 30 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This contract award, valued at $26,258.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order for the supply of OTEZLA 30 MG TABLET 60S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $6,812.31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and held by Amerisourcebergen with the DLA Troop Support Medical. The IDC serves as...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The current award, valued at $11,247.15, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to support military healthcare...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR8QUDelivery Order
This federal contract award, with a ceiling value of $73,941.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific award is for the supply of OTEZLA 30 MG TABLET 60S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in the federal medical supply market, particularly with the DLA and military healthcare systems, position the company as a key vendor for delivering critical pharmaceutical and medical products to support the healthcare needs of U.S. military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $73.9k | 12/12/23 |